We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
ACC.24 - Akshay Desai shares the findings of the phase 2 KARDIA-2 trial. “Treatment with zilebesiran seems to be an effective therapy to incrementally reduce blood pressure in patients with mild-to-moderate hypertension despite treatment with indapamide, amlodipine or olmesartan”, says Akshay Desai.
This video was recorded in response to a presentation at the Congress of the American College of Cardiology (ACC) 2024.
Akshay Suvas Desai, MD is a cardiovascular medicine specialist and the director of the Cardiomyopathy and Heart Failure Program at Brigham and Women’s Hospital, Boston, MA, US. In addition, he is an associate professor of medicine at Harvard Medical School, Boston, MA, US.
This recording was developed under auspices of PACE-CME. Views expressed in the recording are those of the presenter and do not necessarily reflect the views of PACE-CME.
Release date: 17 april 2024
ACC.24 - Akshay Desai shares the findings of the phase 2 KARDIA-2 trial. “Treatment with zilebesiran seems to be an effective therapy to incrementally reduce blood pressure in patients with mild-to-moderate hypertension despite treatment with indapamide, amlodipine or olmesartan”, says Akshay Desai.
This video was recorded in response to a presentation at the Congress of the American College of Cardiology (ACC) 2024.
Akshay Suvas Desai, MD is a cardiovascular medicine specialist and the director of the Cardiomyopathy and Heart Failure Program at Brigham and Women’s Hospital, Boston, MA, US. In addition, he is an associate professor of medicine at Harvard Medical School, Boston, MA, US.
This recording was developed under auspices of PACE-CME. Views expressed in the recording are those of the presenter and do not necessarily reflect the views of PACE-CME.
Release date: 17 april 2024
Stay current with the best on medical education
